glp-1 agonist therapy consultation preparation Application of nutrition interventions with based therapies: A narrative review of the challenges and solutions aGLP-1 receptor agonists & anesthesia:

Nature Reviews Gastroenterology & Hepatology , 16(1), 3556

Patients who want to track lean mass separately from total weight can discuss DEXA scanning or clinical body composition assessment

Lixisenatide Lixisenatide was developed by Sanofi-Aventis in France

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper

Verma S, Leiter LA, Mazer CD, Bain SC, Buse J, Marso S, et al

Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide